Benzinga's Top #PreMarket Gainers

shares rose 7.88% to $19.04 in pre-market trading after the company announced its plans to acquire the U.S. rights to NUCYNTA franchise from Johnson & Johnson

subsidiary Janssen Pharmaceuticals, Inc. for $1.05 billion.

shares gained 3.72% to $37.06 in the pre-market trading session. A judge said that BP was not grossly negligent in source control planning.

gained 2.90% to $2.48 in pre-market trading after dropping 8.02% on Thursday.

shares surged 1.60% to $29.80 in pre-market trading after the company priced 12 million shares of common stock at $29.33 per share.

shares jumped 1.22% to $327.70 in pre-market trading. Analysts at Cowen & Company upgraded Netflix from Market Perform to Outperform and raised the price target from $360 to $382.